Safety data from trials In a paper summarizing 6 randomized, double-blind, placebo-controlled human trials, AOD 9604 did not significantly affect IGF-1 levels, did not impair glucose tolerance, and no serious adverse events (SAEs) were attributed to AOD 9604
Thymosin Alpha-1 (TA-1) Helps support immune function and overall resilience by modulating immune response
Future research: Its crucial to acknowledge that the majority of these studies have been performed in vitro or on animal subjects
Some see it as a promising compound, while others are skeptical due to limited human trials
You may get impatient or be prone to mood swings
The second myth is that more is always better, and that often triggers irritation, more breakouts, and more redness, especially when someone layers too many actives at once